Constitutive Activation of the Gsα Protein-Adenylate Cyclase Pathway May Not Be Sufficient to Generate Toxic Thyroid Adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 5, 1996, Pages 1898-1904

  Derwahl, Michael ^a,e   Hamacher, Christiane ^a   Russo, Diego ^c   Broecker, Martina ^a   Manole, Diana ^a   Schatz, Helmut ^a   Kopp, Peter ^d,f   Filetti, Sebastiano ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b Dipto di Med Sperim e Clinica   (Italy)

^c Cattedra di Neurologia   (Italy)

^d NORTHWESTERN UNIVERSITY   (United States)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f Swiss National Foundation of Science

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; GUANINE NUCLEOTIDE BINDING PROTEIN; THYROTROPIN; THYROTROPIN RECEPTOR; CYCLIC AMP; RECEPTOR SUBUNIT;

ADENOMA; ARTICLE; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POINT MUTATION; THYROID TUMOR; ALPHA CHAIN; ENZYME MECHANISM; HUMAN CELL; HUMAN TISSUE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SIGNAL TRANSDUCTION; THYROID ADENOMA; TOXIC GOITER;

ADENOMA; ADENYLATE CYCLASE; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; ENZYME ACTIVATION; GENE EXPRESSION; GTP-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; POINT MUTATION; RECEPTORS, THYROTROPIN; THYROID NEOPLASMS; THYROTROPIN;

EID: 0029664322     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.81.5.8626855     Document Type: Article

References (44)

1. Studer H, Derwahl M. 1995 Mechanisms of nonneoplastic endocrine hyperplasia-a changing concept: a review focused on the thyroid gland. Endocr Rev. 16:411-426.
2. Namba H, Matsuo K, Fagin JA. 1990 Clonal composition of benign and malignant human thyroid tumors. J Clin Invest. 86:120-125.
3. Thomas GA, Williams D, Williams ED. 1989 The clonal origin of thyroid nodules and adenomas. Am J Pathol. 134:141-147.
4. Kopp P, Kimura ET, Aeschiman S, et al. 1994 Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters. J Clin Endocrinol Metab. 79:134-139.
5. Nicolson GL. 1987 Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res. 47:1473-1487.
6. Fearon ER, Vogelstein B. 1990 A genetic model for colorectal tumorigenesis. Cell. 61:759-767.
7. Wynford-Thomas D. 1993 Molecular genetics of thyroid cancer. Trends Endocrinol Metab. 4:224-232.
8. Farid NR, Yufei SHI, Minjing Z. 1994 Molecular basis of thyroid cancer. Endocr Rev. 15:221-230.
9. Esapa C, Foster SA, Turmer J, Kendall-Taylor P, Jameson JL, Harris PE. Oncogenetic mutations of the TSH receptor and G proteins in thyroid neoplasia [Abstract]. Proc of the 77th Annual Meet of The Endocrine Soc. 1995;3-430.
10. Lyons J, Landis CA, Harsh G, et al. 1990 Two G protein oncogenes in human endocrine tumors. Science. 249:655-659.
11. O'Sullivan CD, Barton M, Staddon SL, Brown CL, Lemoine NR. 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog. 4:354-357.
12. Parma J, Duprez L, Van Sande J, et al. 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:649-651.
13. Russo D, Arturi F, Wicker R, et al. 1995 Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 80:1347-1351.
14. 2+ cascades. Mol Endocrinol. 9:725-733.
15. Porcellini A, Tassi V, Ciullo I, et al. 1995 Studies on the prevalence of TSH-R mutations in a large series of consecutive hyperfunctioning thyroid adenomas [Abstract 15]. Thyroid. 5(Suppl 1):S-8.
16. Nagayama Y, Takeshita A, Ishikawa N, Yamashita T, Obara T. 1995 Rarity of oncogenic mutations in the TSH receptor of autonomously functioning thyroid nodules in Japan [Abstract 274]. Thyroid. 5(Suppl 1):S-138.
17. Dumont JE, Jauniaus JC, Roger PP. 1989 The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci. 14:67-71.
18. Ledent C, Dumont JE, Vassart G, Parmentier M. 1992 Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J. 11:537-542.
19. Hamacher Ch, Studer H, Zbaeren J, Schatz H, Derwahl M. 1995 Expression of functional stimulatory G protein in non-functioning thyroid adenomas is not correlated to adenylate cyclase activity and growth in these tumors. J Clin Endocrinol Metab. 80:1724-1732.
20. Kopp P, van Sande J, Parma J, et al. 1995 Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med. 332:150-154.
21. McKenzie FR. 1992 Plasma membrane production. In: Milligan G, ed. Signal transduction: a practical approach. Oxford: IRL Press; 33-34.
22. s and cyclic AMP generation in HIT cells. J Biol Chem. 264:21106-21111.
23. Duh QY, Siperstein AE, Miller RA, Smeds S, Clark OH. 1989 TSH binding correlates with TSH-stimulated thyroid adenylate cyclase activity in human thyroid tissues. Surgery. 106:967-974.
24. Siperstein AE, Miller RA, Landis C, Bourne HR, Clark OH. 1991 Increased stimulatory G protein in neoplastic human thyroid tissue. Surgery. 110:949-955.
25. Johnson RA, Salomon X. 1991 Assay of adenylyl cyclase activity. Methods Enzymol. 195:32-41.
26. Sambrook J, Fritsch EF, Maniatis T. 1989 Molecular cloning-A laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory; vol 1-3.
27. Derwahl M, Seto P, Rapoport B. 1990 An abnormal splice donor site in one allele of the thyroid peroxidase gene in FRTL5 rat thyroid cells introduces a premature stop codon: association with the absence of functional enzymatic activity. Mol Endocrinol. 4:793-799.
28. Gilman AG. 1987 G proteins transducers of receptor-generated signals. Annu Rev Biochem. 56:615-649.
29. Hadcock JR, Ros M, Watkins DC, Malbon CC. 1990 Cross-regulation between G-protein-mediated pathways. J Biol Chem. 265:14784-14790.
30. Hadcock JR, Port JD, Malbon CC. 1991 Cross-regulation between G-protein-mediated pathways. J Biol Chem. 266:11915-11922.
31. Rentsch H, Studer H, Frauchiger B, Siebenhüner L. 1981 Topographical heterogeneity of basal and thyrotropin-stimulated adenosine 3′,5′monophosphate in human nodular goiter. J Clin Endocrinol Metab. 53:514-521.
32. s protein. Thyrotropin and forskolin increase the quantity of stimulatory guanine nucleotide-binding proteins in cultured follicles. J Biol Chem. 265:19942-19946.
33. Derwahl M, Hamacher C, Papageorgiou G, Schatz H. 1995 Altered regulation of the stimulatory G protein (Gs)-adenylate cyclase cascade in differentiated thyroid carcinomas: evidence for upregulation of inhibitory G protein by Gs protein [Abstract 5]. Thyroid. 5(Suppl 1):S-3.
34. Kimura ET, Zbaeren J, Aeschimann S, Studer H. 1994 Expression of transforming growth factor β (TGFβ) 1 and 3 in benign and malignant human thyroid glands [Abstract 172]. Thyroid. 4(Suppl 1):S-12.
35. Logan A, Smith C, Becks GP, Gonzalez AM, Philips ID, Hill DJ. 1994 Enhanced expression of transforming growth factor-β1 during thyroid hyperplasia in rats. Endocrinology. 141:45-57.
36. Chiariotti L, Berlingieri MT, De Rosa P, et al. 1992 Increased expression of the negative growth factor, galactoside binding protein gene in transformed thyroid cells and in human thyroid carcinomas. Oncogene. 7:2507-2511.
37. Selzer E, Wilfing A, Schifferer A, Hermann M, Grubeck-Loebenstein B, Freissmuth M. 1993 Stimulation of human thyroid growth via the inhibitory guanine nucleotide binding (G) protein Gi: constitutive expression of the G-protein alpha subunit Gi alpha-1 in autonomous adenoma. Proc Natl Acad Sci USA. 90:1609-1613.
38. Tang WJ, Gilman AG. 1992 Adenylyl cyclases. Cell. 70:869-872.
39. Michiels FM, Caillou B, Talbot M, et al. 1994 Oncogenic potential of guanine nucleotide stimulatory factors a subunit in thyroid glands of transgenic mice. Proc Natl Acad Sci USA. 91:10488-10492.
40. Studer H, Huber G, Derwahl M, Frey P. 1989 Die Umwandlung von Basedowstrumen in Knotenkröpfe: ein Grund des Hyperthyreoserezidivs. Schweiz Med Wochenschr. 119:203-208.
41. Abs R, Stevenaert A, Beckers A. 1994 Autonomously functioning thyroid nodules in a patient with a thyrotropin-secreting pituitary adenoma: possible cause-effect relationship. Eur J Endocrinol. 131:355-358.
42. Muca C, Vallar L. 1994 Expression of mutationally activated Gαs stimulates growth and differentiation of thyroid FRTL5 cells. Oncogene. 9:3647-3653.
43. Saji M, Levine MA, Zeiger MA. 1994 An in vitro model of thyroid neoplasia: permanently transfected FRTL5 cells with thyroglobulin promotor-cholera toxin A1 subunit minigene. Surgery. 116:1048-1053.
44. Alexander P. 1985 Do cancers arise from a single transformed cell or is monoclonality of tumours a late event in carcinogenesis? Br J Cancer. 51:453-457.